CompletedNCT04302688Updated Mar 10, 2020

Accurate Classification System for Patients With COVID-19 Pneumonitis

An observational study in Pneumonitis, sponsored by Renmin Hospital of Wuhan University. Completed at 1 site in China. Per ClinicalTrials.gov, last updated 2020-03-10.

Sponsored by Renmin Hospital of Wuhan University · Observational

Study type: Observational
Model: Other
Time perspective: Retrospective
Enrollment: 669
Sex: All

Study summary

The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-19 pneumonia grading scale. The COVID-19 score system was validated to predict the clinical outcome of a patient.

Read the detailed description

First we collect the medical records, according to the time sequence, the patients were divided into two groups, one is the model group, and the other is the validate group.
Responsible for the risk factor of regression equation according to the model. The patients were divided into three groups according to their total score of risk responsibility.
Compared with SEPSIS and CURB-65 grading system with the grading system we established.

Conditions studied

Pneumonitis

Browse trials for

Pneumonia 2,044

In context

Pneumonia

2,044 studies on the registry are indexed under Pneumonia; 283 are open to participants now.

This study's enrollment of 669 is above the median of 203 across 688 observational studies indexed under Pneumonia.

Browse Pneumonia studies →

Lead sponsor

Renmin Hospital of Wuhan University is the lead sponsor of 83 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

Patients with novel coronavirus pneumonia, and all cases were collected from the People's Hospital of Wuhan University.

Inclusion criteria

Patients with novel coronavirus pneumonia should be examined and diagnosed by CT and swab test of viral nucleic acid.

Exclusion criteria

Exclusion Criteria:

Patients who should have died during the course of the disease, but the cause of death was unrelated to viral pneumonia.
Suspected patient review refers to the negative nucleic acid test.

Study design

Observational model: Other
Time perspective: Retrospective
Enrollment: 669 participants (actual)
Patient registry: No

Groups and cohorts

modeling cohort
The 445 patients were grouped in chronological order.
validating colort
The remaining 224 patients.

What researchers measure

Primary outcomes

survival status
survival status as of February 24, 2020
Time frame: 10 December 2019 to 10 February 2020

Study locations

1 site

Renmin Hospital of Wuhan University
Wuhan, Hubei 430060, China

References and documents

Individual participant data

Plan to share: No — Not going to share for the time being.

No publications or documents are linked to this record.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Mar 10, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT04302688
Lead sponsor: Renmin Hospital of Wuhan University
Responsible party: Gong Qiong (Professor, Renmin Hospital of Wuhan University) — Principal investigator
First posted: Mar 10, 2020
Start date: Dec 10, 2019
Primary completion: Feb 10, 2020
Completion: Mar 4, 2020
Last update: Mar 10, 2020

Study contacts

Qiong Gong, MD.

principal investigator · Renmin Hospital of Wuhan University

Oversight

FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Pneumonia→

Other studies from this sponsor

Renmin Hospital of Wuhan University

Start the discussion